Synthesis, biological evaluation and in silico studies of novel thiadiazole-hydrazone derivatives for carbonic anhydrase inhibitory and anticancer activities

References

• M. Tapera, H. Kekeçmuhammed, B. Tüzün, E. Sarıpınar, Ü.M. Koçyiğit, E. Yıldırım, M. Doğan, and Y. Zorlu, Synthesis, carbonic anhydrase inhibitory activity, anticancer activity and molecular docking studies of new imidazolyl hydrazone derivatives, J. Mol. Struct. 1269 (2022), pp. 133816. doi:10.1016/j.molstruc.2022.133816.
   Web of Science ®Google Scholar
• S. Bilginer, S.K. Bardaweel, Y. Demir, I. Gulcin, and C. Kazaz, Synthesis, cytotoxicities, and carbonic anhydrase inhibition activities of pyrazoline–benzenesulfonamide derivatives harboring phenol/polyphenol moieties, Med. Chem. Res. 31 (2022), pp. 925–935. doi:10.1007/s00044-022-02893-z.
   Web of Science ®Google Scholar
• V. Chahal and R. Kakkar, A combination strategy of structure-based virtual screening, MM-GBSA, cross docking, molecular dynamics and metadynamics simulations used to investigate natural compounds as potent and specific inhibitors of tumor linked human carbonic anhydrase IX, J. Biomol. Struct. Dyn. 41 (2023), pp. 5465–5480. doi:10.1080/07391102.2022.2087736.
   PubMed Web of Science ®Google Scholar
• H.O. Tawfik, M.A. Shaldam, A. Nocentini, R. Salem, H. Almahli, S.T. Al-Rashood, C.T. Supuran, and W.M. Eldehna, Novel 3-(6-methylpyridin-2-yl) coumarin-based chalcones as selective inhibitors of cancer-related carbonic anhydrases IX and XII endowed with anti-proliferative activity, J. Enz. Inhib. Med. Chem. 37 (2022), pp. 1043–1052. doi:10.1080/14756366.2022.2056734.
   PubMed Web of Science ®Google Scholar
• H.O. Tawfik, A. Belal, M.A. Abourehab, A. Angeli, A. Bonardi, C.T. Supuran, and M.H. El-Hamamsy, Dependence on linkers’ flexibility designed for benzenesulfonamides targeting discovery of novel hCA IX inhibitors as potent anticancer agents, J. Enz. Inhib. Med. Chem. 37 (2022), pp. 2765–2785. doi:10.1080/14756366.2022.2130285.
   PubMed Web of Science ®Google Scholar
• A. Bonardi, S. Bua, J. Combs, C. Lomelino, J. Andring, S.M. Osman, A. Toti, L.D.C. Mannelli, P. Gratterib, C. Lomelinoc, R. McKenna, A. Nocentini, and C.T. Supuran, The three-tails approach as a new strategy to improve selectivity of action of sulphonamide inhibitors against tumour-associated carbonic anhydrase IX and XII, J. Enz. Inhib. Med. Chem. 37 (2022), pp. 930–939. doi:10.1080/14756366.2022.2053526.
   PubMed Web of Science ®Google Scholar
• A.I. Zain-Alabdeen, T.F. El-Moselhy, N. Sharafeldin, A. Angeli, C.T. Supuran, and M.H. El-Hamamsy, Synthesis and anticancer activity of new benzensulfonamides incorporating s-triazines as cyclic linkers for inhibition of carbonic anhydrase IX, Sci. Rep. 12 (2022), pp. 16756. doi:10.1038/s41598-022-21024-7.
   PubMed Web of Science ®Google Scholar
• A. Kumar, K. Siwach, C.T. Supuran, and P.K. Sharma, A decade of tail-approach based design of selective as well as potent tumor associated carbonic anhydrase inhibitors, Bioorg. Chem. 126 (2022), pp. 105920. doi:10.1016/j.bioorg.2022.105920.
   PubMed Web of Science ®Google Scholar
• G. Arrighi, A. Puerta, A. Petrini, F.J. Hicke, A. Nocentini, M.X. Fernandes, J.M. Patron, C.T. Supuran, J.G. Fernández-Bolaños, and Ó. López, Squaramide-tethered sulfonamides and coumarins: Synthesis, inhibition of tumor-associated cas ix and xii and docking simulations, Int. J. Mol. Sci. 23 (2022), pp. 7685.
   PubMed Web of Science ®Google Scholar
• H.O. Tawfik, A. Petreni, C.T. Supuran, and M.H. El-Hamamsy, Discovery of new carbonic anhydrase IX inhibitors as anticancer agents by toning the hydrophobic and hydrophilic rims of the active site to encounter the dual-tail approach, Eur. J. Med. Chem. 232 (2022), pp. 114190. doi:10.1016/j.ejmech.2022.114190.
   PubMed Web of Science ®Google Scholar
• T. Al-Warhi, M.M. Elbadawi, A. Bonardi, A. Nocentini, A.A. Al-Karmalawy, N. Aljaeed, O.J. Alotaibi, H.A. Abdel-Aziz, C.T. Supuran, and W.M. Eldehna, Design and synthesis of benzothiazole-based SLC-0111 analogues as new inhibitors for the cancer-associated carbonic anhydrase isoforms IX and XII, J. Enz. Inhib. Med. Chem. 37 (2022), pp. 2635–2643. doi:10.1080/14756366.2022.2124409.
   PubMed Web of Science ®Google Scholar
• L. Micheli, L. Testai, A. Angeli, D. Carrino, A. Pacini, F. Margiotta, L. Flori, C.T. Supuran, V. Calderone, C. Ghelardini, and L.D.C. Mannelli, Inhibitors of mitochondrial human carbonic anhydrases VA and VB as a therapeutic strategy against paclitaxel-induced neuropathic pain in mice, Int. J. Mol. Sci. 23 (2022), pp. 6229. doi:10.3390/ijms23116229.
   PubMed Web of Science ®Google Scholar
• D.M. Elimam, W.M. Eldehna, R. Salem, A. Bonardi, A. Nocentini, S.T. Al-Rashood, M.M. Elaasser, P. Gratteri, C.T. Supuran, and H.A. Allam, Natural inspired ligustrazine-based SLC-0111 analogues as novel carbonic anhydrase inhibitors, Eur. J. Med. Chem. 228 (2022), pp. 114008. doi:10.1016/j.ejmech.2021.114008.
   PubMed Web of Science ®Google Scholar
• B.D. Vanjare, N.G. Choi, Y.S. Eom, H. Raza, M. Hassan, K.H. Lee, and S.J. Kim, Synthesis, carbonic anhydrase inhibition, anticancer activity, and molecular docking studies of 1,3,4-oxadiazole derivatives, Mol. Divers. 27 (2023), pp. 193–208. doi:10.1007/s11030-022-10416-6.
   PubMed Web of Science ®Google Scholar
• Ö. Güleç, C. Türkeş, M. Arslan, Y. Demir, Y. Yeni, A. Hacımüftüoğlu, E. Ereminsoy, Ö.İ. Küfrevioğlu, and Ş. Beydemir, Cytotoxic effect, enzyme inhibition, and in silico studies of some novel N-substituted sulfonyl amides incorporating 1, 3, 4-oxadiazol structural motif, Mol. Divers. 26 (2022), pp. 2825–2845. doi:10.1007/s11030-022-10422-8.
   PubMed Web of Science ®Google Scholar
• N. Chu, Y. Wang, H. Jia, J. Han, X. Wang, and Z. Hou, Design, Synthesis and biological evaluation of new carbohydrate-based coumarin derivatives as selective carbonic anhydrase ix inhibitors via “click” reaction, Molecules 27 (2022), pp. 5464. doi:10.3390/molecules27175464.
   PubMed Web of Science ®Google Scholar
• M.A. Abdelgawad, S.N. Bukhari, A. Musa, M. Elmowafy, M.H. Elkomy, A.A. Nayl, A.H. El-Ghorab, I.O. Althobaiti, H.A. Altaleb, H. Omar, A.H. Abdelazeem, M.A. Zaki, M.E. Shaker, and H.A.H. Elshemy, New sulfamethoxazole derivatives as selective carbonic anhydrase ix and xii inhibitors: Design, synthesis, cytotoxic activity and molecular modeling, Pharm. 15 (2022), pp. 1134.
   Google Scholar
• B. Zengin Kurt, G. Celebi, D. Ozturk Civelek, A. Angeli, A. Akdemir, F. Sonmez, and C.T. Supuran, Tail-approach-based design and synthesis of coumarin-monoterpenes as carbonic anhydrase inhibitors and anticancer agents, ACS Omega 8 (2023), pp. 5787–5807. doi:10.1021/acsomega.2c07459.
   PubMedGoogle Scholar
• S. Bondock, T. Albarqi, T. Nasr, N.M. Mohamed, and M.M. Abdou, Design, synthesis, cytotoxic evaluation and molecular docking of novel 1,3,4-thiadiazole sulfonamides with azene and coumarin moieties as carbonic anhydrase inhibitors, Arab. J. Chem. 16 (2023), pp. 104956. doi:10.1016/j.arabjc.2023.104956.
   Web of Science ®Google Scholar
• J. Yang, D.L. Chen, P.C. Wang, B. Yang, and C.Z. Gao, NIR phosphorescent cyclometalated platinum (II) complexes with CAIX targeted and nuclear penetration as potent anticancer theragnostic agents, Eur. J. Med. Chem. 243 (2022), pp. 114702. doi:10.1016/j.ejmech.2022.114702.
   PubMed Web of Science ®Google Scholar
• A. Elkamhawy, J. Woo, H. Nada, A. Angeli, T.M. Bedair, C.T. Supuran, and K. Lee, Identification of novel and potent indole-based benzenesulfonamides as selective human carbonic anhydrase ii inhibitors: Design, synthesis, in vitro, and in silico studies, Int. J. Mol. Sci. 23 (2022), pp. 2540. doi:10.3390/ijms23052540.
   PubMed Web of Science ®Google Scholar
• H.T. Abdel‐Mohsen, M.A. Omar, A. Petreni, and C.T. Supuran, Novel benzenesulfonamide‐thiouracil conjugates with a flexible N‐ethyl acetamide linker as selective CA IX and CA XII inhibitors, Arch. Pharm. 356 (2023), pp. 2200434. doi:10.1002/ardp.202200434.
   Web of Science ®Google Scholar
• H. Nada, A. Elkamhawy, M.H. Abdellattif, A. Angeli, C.H. Lee, C.T. Supuran, and K. Lee, 4-anilinoquinazoline-based benzenesulfonamides as nanomolar inhibitors of carbonic anhydrase isoforms I, II, IX, and XII: Design, synthesis, in-vitro, and in-silico biological studies, J. Enzyme Inhib. Med. Chem. 37 (2022), pp. 994–1004. doi:10.1080/14756366.2022.2055553.
   PubMed Web of Science ®Google Scholar
• S. Janowska, D. Khylyuk, A. Gornowicz, A. Bielawska, M. Janowski, R. Czarnomysy, K. Bielawski, and M. Wujec, Synthesis and anticancer activity of 1, 3, 4-thiadiazoles with 3-methoxyphenyl substituent, Molecules 27 (2022), pp. 6977. doi:10.3390/molecules27206977.
   PubMed Web of Science ®Google Scholar
• S. Janowska, D. Khylyuk, A. Bielawska, A. Szymanowska, A. Gornowicz, K. Bielawski, J. Noworól, S. Mandziuk, and M. Wujec, New 1,3,4-thiadiazole derivatives with anticancer activity, Molecules (2022), pp. 1814. doi:10.3390/molecules27061814.
   PubMedGoogle Scholar
• S.A. Ibrahim, M.M. Salem, H.A. Abd Elsalam, and A.A. Noser, Design, synthesis, in-silico and biological evaluation of novel 2-amino-1, 3, 4-thiadiazole based hydrides as B-cell lymphoma-2 inhibitors with potential anticancer effects, J. Mol. Struct. 1268 (2022), pp. 133673. doi:10.1016/j.molstruc.2022.133673.
   Web of Science ®Google Scholar
• M. Vilková, M. Hudáčová, N. Palušeková, R. Jendželovský, M. Almáši, T. Béres, P. Fedoročko, and M. Kožurková, Acridine based n-acylhydrazone derivatives as potential anticancer agents: Synthesis, characterization and ctdna/hsa spectroscopic binding properties, Molecules 27 (2022), pp. 2883. doi:10.3390/molecules27092883.
   PubMed Web of Science ®Google Scholar
• Y. Demir, F.S. Tokalı, E. Kalay, C. Türkeş, P. Tokalı, O.N. Aslan, K. Şendil, and Ş. Beydemir, Synthesis and characterization of novel acyl hydrazones derived from vanillin as potential aldose reductase inhibitors, Mol. Divers. (2022), pp. 1–21. doi:10.1007/s11030-022-10526-1.
   Web of Science ®Google Scholar
• S. Al Bitar and H. Gali-Muhtasib, The role of the cyclin dependent kinase inhibitor p21cip1/waf1 in targeting cancer: Molecular mechanisms and novel therapeutics, Cancers 11 (2019), pp. 1475. doi:10.3390/cancers11101475.
   PubMed Web of Science ®Google Scholar
• A. Işık, U.A. Çevik, I. Çelik, H.E. Bostancı, A. Karayel, G. Gündoğdu, U. İnce, A. Koçak, Y. Özkay, and Z.A. Kaplancıklı, Benzimidazole-hydrazone derivatives: Synthesis, in vitro anticancer, antimicrobial, antioxidant activities, in silico DFT and ADMET studies, J. Mol. Struct. 1270 (2022), pp. 133946. doi:10.1016/j.molstruc.2022.133946.
   Web of Science ®Google Scholar
• F. Sozmen, M. Kucukoflaz, M. Ergul, Z.D.S. Inan, Y. Bozkurt, and D. Taydas, Synthesis of multifunctional organic nanoparticles combining photodynamic therapy and chemotherapeutic drug release, Macromol. Res. 30 (2022), pp. 61–69. doi:10.1007/s13233-022-0021-0.
   Web of Science ®Google Scholar
• N. Valkova, F. Lépine, L. Labrie, M. Dupont, and R. Beaudet, Purification and characterization of prba, a new esterase from Enterobacter cloacae hydrolyzing the esters of 4-hydroxybenzoic acid (parabens), J. Biol. Chem. 278 (2003), pp. 12779–12785. doi:10.1074/jbc.M213281200.
   PubMed Web of Science ®Google Scholar
• E. Henke and U. Bornscheuer, Esterases from Bacillus subtilis and B. stearothermophilus share high sequence homology but differ substantially in their properties, Appl. Microbiol. Biotechnol. 60 (2002), pp. 320–326. doi:10.1007/s00253-002-1126-1.
   PubMed Web of Science ®Google Scholar
• B.E.O. Bedir, E. Terzi, and O.O. Guler, Differential in vitro effects of oncogenic pathway inhibitors on carbonic anhydrase-IX, xanthine oxidase, and catalase in colorectal cancer, Int. J. Med. Biochem. 6 (2023), pp. 36–41.
   Google Scholar
• E.F. Pettersen, T.D. Goddard, C.C. Huang, E.C. Meng, G.S. Couch, T.I. Croll, J.H. Morris, and T.E. Ferrin, UCSF ChimeraX: Structure visualization for researchers, educators, and developers, Protein Sci. 30 (2021), pp. 70–82. doi:10.1002/pro.3943.
   PubMed Web of Science ®Google Scholar
• P.R. Yadav, S.H. Basha, and P.K. Pindi, Role of Thr199 residue in human β-carbonic anhydrase-II pH-dependent activity elucidated by microsecond simulation analysis, J. Biomol. Struct. Dyn. 40 (2022), pp. 5016–5025. doi:10.1080/07391102.2020.1865203.
   PubMed Web of Science ®Google Scholar
• J. Leitans, A. Kazaks, A. Balode, J. Ivanova, R. Zalubovskis, C.T. Supuran, and K. Tars, Efficient expression and crystallization system of cancer-associated carbonic anhydrase isoform IX, J. Med. Chem. 58 (2015), pp. 9004–9009. doi:10.1021/acs.jmedchem.5b01343.
   PubMed Web of Science ®Google Scholar
• A. Daina, O. Michielin, and V. Zoete, SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules, Sci. Rep. 7 (2017), pp. 42717. doi:10.1038/srep42717.
   PubMed Web of Science ®Google Scholar
• B.Y. Peng, A.K. Singh, C.H. Chan, Y.H. Deng, P.Y. Li, C.W. Su, C.Y. Wu, and W.P. Deng, AGA induces sub-G1 cell cycle arrest and apoptosis in human colon cancer cells through p53-independent/p53-dependent pathway, BMC Cancer 23 (2023), pp. 1–13. doi:10.1186/s12885-022-10466-x.
   PubMed Web of Science ®Google Scholar